back to Meetings page
- IMMPACT-XIII
- June 24-25, 2010
- Hyatt Regency Bethesda
- Bethesda, Maryland
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
- Robert H. Dworkin, PhD (University of Rochester)
- Academia and Related Participants
- Misha-Miroslav Backonja, MD (University of Wisconsin)
- Ralf Baron, Dr med (University of Kiel)
- Nicholas Bellamy, MD (University of Queensland)
- John T. Farrar, MD, PhD (University of Pennsylvania)
- Ian Gilron, MD (Queen's University)
- Mark P. Jensen, PhD (University of Washington)
- Nathaniel P. Katz, MD (Analgesic Research and Tufts University)
- John D. Markman, MD (University of Rochester)
- Michael McDemott, PhD (University of Rochester)
- Sarah Peirce-Sandner, MS (University of Rochester)
- Srinivasa N. Raja, MD (Johns Hopkins University)
- Andrew S. C. Rice, MD (Imperial College London)
- Michael C. Rowbotham, MD (University of California San Francisco)
- Cristina Sampaio, MD, PhD (Faculdade de Medicina de Lisboa)
- Brett Stacey, MD (Oregon Health and Science University)
- Ajay D. Wasan, MD (Harvard Medical School)
- George A. Wells, PhD (University of Ottawa Heart Institute)
- Dan Ziegler, MD (Heinrich Heine University)
- Government Participants
- Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
- Ann Costello, DMD, PhD (US Food and Drug Administration)
- Sharon Hertz, MD (US Food and Drug Administration)
- Robert D. Kerns, PhD (VA Connecticut Healthcare System)
- Linda Porter, PhD (National Institutes of Health)
- Bob A. Rappaport, MD (US Food and Drug Administration)
- Anne Marie Trentacosti, MD (US Food and Drug Administration)
- James Witter, MD, PhD (National Institutes of Health)
- Patient Representative
- Penney Cowan (American Chronic Pain Association)
- Industry Participants
- Zubin Bhagwagar, MD, PhD (Bristol-Myers Squibb)
- Weikai Chistopher Fang, MD (DePuy Spine)
- Gary Jay, MD (Pfizer)
- Roderick Junor, PhD, MB (Eisai Limited)
- Rosemary Kerwin, Pharm D (Nuvo Pharmaceuticals)
- Ernest Kopecky, PhD, MBA (Endo Pharmaceuticals)
- Dmitri Lissin, MD (Durect Corporation)
- Richard Malamut, MD (AstraZeneca Pharmaceuticals)
- Catherine Munera, PhD (Purdue Pharma)
- Christine Rauschkolb, MD, PhD (Johnson & Johnson)
- Vladimir Skljarevski, MD (Eli Lilly & Co.)
- Kenneth Sommerville, MD (King Pharmaceuticals)
- Ilona Steigerwald, MD, PhD (Grunenthal GmbH)
- Jeffrey Tobias, MD (NeurogesX)
- Jim Williams, PhD (Smith & Nephew)